Waters Corporation (WAT) — chart, structure and Closelook read

Pick a ticker to load its detail page.

Company snapshot — Waters Corporation

WAT in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Waters makes liquid chromatography and mass spectrometry instruments that separate and identify compounds in a sample, along with the columns and consumables those instruments use up. It also sells thermal analysis, rheometry and calorimetry tools that test how materials behave under heat and stress, plus software that runs its own and other makers' instruments. Customers span pharmaceutical, clinical, industrial and academic laboratories that need to verify what a substance contains or how stable it is. It is based in Milford, Massachusetts.
Where it sits in the stack
Waters carries no seat in our index, so it sits in the Healthcare sector of our universe, in the diagnostics-and-research sleeve rather than the AI build-out stack. Its instruments serve drug discovery and quality-control labs, a demand line tied to pharmaceutical and biotech research budgets rather than to compute or chip capacity.
Who it is priced against
Our diary has not set a peer group for this name; the comparison the market draws is with Agilent Technologies, another maker of laboratory analytical instruments.
Why Closelook tracks it
It is an S&P 500 constituent; it does not yet carry a Closelook score and has not been quoted in our editions.
What the diary watches
Whether pharmaceutical and biotech research spending, which drives instrument and consumable orders, holds up or slows as lab budgets are set.

Waters Corporation (WAT) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for WAT, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Diagnostics & Research · United States · 8 names with week and year-to-date

Peer group

Diagnostics & Research · United States

This name carries no Closelook score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against WAT on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Waters Corporation (WAT)?

Waters Corporation trades as WAT on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is WAT in a Closelook index?

Not currently — Waters Corporation is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does WAT trade against its moving averages?

Uptrend stack intact: Trades +8.1% vs the 50-day and +18.9% vs the 200-day average, 0.5% below the 52-week high and +52% off the 52-week low; a golden cross printed 55 sessions ago. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Waters Corporation do?

Waters makes liquid chromatography and mass spectrometry instruments that separate and identify compounds in a sample, along with the columns and consumables those instruments use up. It also sells thermal analysis, rheometry and calorimetry tools that test how materials behave under heat and stress, plus software that runs its own and other makers' instruments. Customers span pharmaceutical, clinical, industrial and academic laboratories that need to verify what a substance contains or how stable it is. Our diary has not set a peer group for this name; the comparison the market draws is with Agilent Technologies, another maker of laboratory analytical instruments.

Where does Waters Corporation sit in the AI build-out?

Waters carries no seat in our index, so it sits in the Healthcare sector of our universe, in the diagnostics-and-research sleeve rather than the AI build-out stack. Its instruments serve drug discovery and quality-control labs, a demand line tied to pharmaceutical and biotech research budgets rather than to compute or chip capacity. It is an S&P 500 constituent; it does not yet carry a Closelook score and has not been quoted in our editions.

What does this page show?

A live price chart with SMA overlays and drawing tools for WAT, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe

then Diagnostics & Research. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.